Consensus Statement on the Management of Comorbidity in Patients with Rheumatoid Arthritis and Psoriasis

Castañeda, Santos; Loza, Estíbaliz; Daudén, Esteban; Carmona, Loreto

doi:10.3899/jrheum.151028

Cited by 3 publications

(1 citation statement)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) recommend that all PsA patients should be encouraged to achieve and maintain a healthy body weight [23]. Similarly, recommendations from Spanish expert panels emphasise the importance of screening for CV disease and management in a multidisciplinary environment including promotion of regular exercise, healthy body weight and smoking cessation for patients with RA and PsA [24–26]. The Australian guidelines for the management of absolute CV disease risk also include a consensus-based recommendation that lifestyle advice and support be given to all adults, even those assessed to have low CV risk [27].…”

Section: Introductionmentioning

confidence: 99%

Cardiovascular risk management in rheumatoid and psoriatic arthritis: online survey results from a national cohort study

et al. 2018

View full text Add to dashboard Cite

Background Chronic inflammatory arthritis is associated with increased cardiovascular (CV) morbidity and mortality. Pharmacological management and healthy lifestyle modification is recommended to manage these risks, but it is not known how often these are utilised and whether there is any difference in their use between patients with different types of arthritis. The aim of this study was to determine and compare the proportion of participants with rheumatoid arthritis (RA) and psoriatic arthritis (PsA) receiving pharmacological or lifestyle management strategies for CV risk factors. The secondary objective was to identify factors associated with use of management strategies. Methods A survey was sent to online participants in the Australian Rheumatology Association Database, a voluntary national registry for inflammatory arthritis. Participants were asked whether they took medications for hypertension, hyperlipidaemia and diabetes, and to report their height, weight, level of physical activity, and dietary changes made. The use of management strategies was compared between participants with RA and PsA. Logistic regression analyses were performed to identify factors associated with physical activity and dietary changes. Results There were 858 respondents with RA and 161 with PsA (response rate 64.5%). Pharmacological treatment was reported by 93% of participants with hypertension and 70% with hyperlipidaemia. All participants with diabetes reported being managed with dietary modification, pharmacological treatment, or a combination of both. Adequate physical activity was reported by 50.8%. Only 27% of overweight or obese participants reported making any dietary change for their health in the past year. There was no difference between RA and PsA in reported utilisation of management strategies. Hyperlipidaemia and being overweight were associated with making dietary change. Obesity and arthritis disease activity were negatively associated with physical activity. Conclusions Most participants with RA and PsA reported using pharmacological treatment for CV risk factors. Relatively few reported using lifestyle modifications. Targeted lifestyle interventions should be implemented for RA and PsA patients. Electronic supplementary material The online version of this article (10.1186/s41927-018-0032-9) contains supplementary material, which is available to authorized users.

show abstract

Section: Introductionmentioning

confidence: 99%